|
Magyar Neuroszonológiai Társaság |
|
8th Annual Meeting of the Hungarian Society of Neurosonology |
Rendezvény kezdete: 2007.05.26. | Rendezvény vége: 2007.05.29. |
Tudományos információ: Prof. Dr. László CSIBA, President of the Hungarian Stroke Society |
Munkahely neve: University of Debrecen Medical and Health Science Center Department of Neurology |
Címe: Nagyerdei krt. 98
H-4012 Debrecen, Hungary |
Tel: +36 52 415 176 |
Fax: +36 52 453 590 |
E-mail: csiba@jaguar.dote.hu |
Helyszín: Budapest, Hunguest Hotels Europa |
12th Meeting of the European Society of Neurosonology and Cerebral Hemodynamics in association with the 13th Meeting of the Neurosonology Research Group of the World Federation of Neurology, in association with the 8th Annual Meeting of the Hungarian Society of Neurosonology.
For more information please see the attached document "Kapcsolódó dokumentumok". |
|
|
 |
|
Magyar Kardiológusok Társasága |
|
International Conference on Early Disease Detection and Prevention (EDDP) |
Rendezvény kezdete: 2010.02.25. | Rendezvény vége: 2010.02.28. |
Helyszín: Németország, München, |
A rendezvény Web oldala: http://www.paragon-conventions.com/EDDP2010 |
This year's EDDP conference will focus on cardiovascular (cardiac disease and hypertension), metabolic (diabetes) and renal diseases. With a scientific program featuring a distinguished international panel of leading speakers, as well as a concurrent exhibition, this conference aims to:
Discuss all elements relevant to early detection of disease prior to its clinical appearance Highlight the most updated technological and other means for disease prevention Encourage a free exchange of ideas among high-caliber presenters and participants Serve as a platform for the biotech/pharma industries to discuss ongoing projects and products Present general principles, ongoing academic/industrial research, and the latest achievements in the field Highlight biotechnological innovations and evaluate their applicability and cost-effectiveness Set the stage for prevention of disease by pharmacological, genetic or other interventional modalities |
|
|
 |